Press Releases
Back to Previous Page
 


News Release
September 19, 2016
Karen Tiano:
+1 978-495-0093

MilliporeSigma’s New Steritest™ Symbio Pump Accessories Enable Faster, Sterility Testing in Any Setting
  • Enhance safety and convenience during sample handling, filtration, waste management, transport and incubation
  • Facilitate testing in compact environments like laminar flow hoods, isolators

Billerica, Massachusetts, September 19, 2016 MilliporeSigma has introduced a set of Steritest™ Symbio Pump systems accessories that accelerate and streamline sterility testing workflows.

The new accessories address testing challenges in various laboratory settings and enhance safety and convenience during sample handling, filtration and waste management as well as canister transport, incubation and reading. The accessories also increase usable space for testing and integrate seamlessly with the Steritest™ Symbio LFH Pump, Symbio ISL Pump and Symbio FLEX Pump in laminar flow hoods, cleanrooms and isolators.

MilliporeSigma has set the standard for reliability and convenience in sterility testing since its first filtration device was introduced in 1974. The new Steritest™ Symbio Pump accessories make MilliporeSigma’s latest sterility testing systems even more reliable, safe and easy to use within any testing environment.

The range of Steritest™ Symbio Pump accessories includes products for sample handling, filtration, waste management, and transport and incubation.

About the Life Science Business of Merck KGaA, Darmstadt, Germany
The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has 19,000 employees and 65 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific discovery. Udit Batra is the global chief executive officer of MilliporeSigma.

Merck KGaA, Darmstadt, Germany completed its $17 billion acquisition of Sigma-Aldrich in November 2015, creating a leader in the $125 billion global life science industry.

Merck KGaA of Darmstadt, Germany is a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials. The company has six businesses – Biopharmaceuticals, Consumer Health, Allergopharma, Biosimilars, Life Science and Performance Materials – and generated sales of € 12.85 billion in 2015. Around 50,000 employees work in 66 countries to improve the quality of life for patients, to foster the success of customers and to help meet global challenges.

Merck KGaA, Darmstadt, Germany is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day. Merck KGaA, Darmstadt, Germany holds the global rights to the name and the trademark “Merck” internationally except for the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.